Beam Therapeutics CFO Terry-Ann Burrell To Resign

Biotechnology company Beam Therapeutics Inc. (BEAM) announced Monday that its chief financial officer, Terry-Ann Burrell, will be leaving the company effective August 9, 2024 to pursue a new opportunity as vice chairman of investment banking at JPMorgan Chase. She served as CFO since August 2019. As part of a transition process, the company has initiated...

Read More

Lupin Divests U.S. Commercial Women\'s Health Specialty Business To Evofem Biosciences

Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women\'s Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical company focused exclusively on Women\'s Health. Lupin\'s U.S. Commercial Women\'s Health Specialty Business is primarily focused on commercializing SOLOSEC (secnidazole) 2g oral granules. This FDA-approved single-dose antimicrobial agent provides a...

Read More

Goldman Sachs Q2 Profit, Revenues Surge

Goldman Sachs Group Inc. (GS) reported Tuesday that net earnings applicable to common shareholders for the second quarter surged to $2.89 billion or $8.62 per share from $1.07 billion or $3.08 per share in the prior-year quarter. On average, 17 analysts polled by Thomson Reuters expected the company to report earnings of $7.64 per share...

Read More

Yen Rises Amid Suspected BOJ Fx Intervention

The Japanese yen strengthened against other major currencies in the Asian session on Friday, as the traders suspect the Bank of Japan (BoJ) may have intervened in the currency markets to prop up the currency. The safe-haven yen rose against the U.S. dollar after soft U.S. inflation data in the month of June raised prospects...

Read More

Lifecore Biomedical To Terminate 46 Full-time Employees Amid Strategic Workforce Reduction Plan

Lifecore Biomedical, Inc. (LFCR) announced Friday that on Monday it determined to implement a strategic reduction of the Company\'s workforce to terminate 46 full-time employees of the Company, representing approximately 9% of the Company\'s workforce, as part of an initiative to strategically optimize the Company\'s cost structure. In connection with the workforce reduction plan, the...

Read More